scholarly journals FP402RELATIVE RISK OF MORTALITY IN HEMODIALYSIS PATIENTS PRESCRIBED CALCIUM-FREE AND CALCIUM-CONTAINING PHOSPHATE BINDING AGENTS

2015 ◽  
Vol 30 (suppl_3) ◽  
pp. iii205-iii205
Author(s):  
J L Fernández-Martín ◽  
M P Dionisi ◽  
J Floege ◽  
M Ketteler ◽  
G London ◽  
...  
2013 ◽  
Vol 84 (5) ◽  
pp. 998-1008 ◽  
Author(s):  
Jorge B. Cannata-Andía ◽  
José L. Fernández-Martín ◽  
Francesco Locatelli ◽  
Gérard London ◽  
José L. Gorriz ◽  
...  

Author(s):  
Pietro Manuel Ferraro ◽  
Davide Bolignano ◽  
Filippo Aucella ◽  
Giuliano Brunori ◽  
Loreto Gesualdo ◽  
...  

2017 ◽  
Vol 32 (suppl_3) ◽  
pp. iii251-iii251
Author(s):  
Naohito Isoyama ◽  
Zenzo Fujii ◽  
Bengt Lindholm ◽  
Koichi Uchiyama ◽  
Hideyasu Matsuyama

2012 ◽  
Vol 7 (9) ◽  
pp. 1435-1445 ◽  
Author(s):  
Tariq Shafi ◽  
Rulan S. Parekh ◽  
Bernard G. Jaar ◽  
Laura C. Plantinga ◽  
Pooja C. Oberai ◽  
...  

2019 ◽  
pp. 78-85
Author(s):  
S. A. Martynov ◽  
M. Sh. Shamkhalova

Hyperphosphatemia in renal pathology is a key factor for developing mineral and bone disorders. It can develop even in the early stages of renal function decline and predict the formation of vascular calcification and an increased risk for developing cardiovascular complications in patients with chronic kidney disease, especially in those, who receive program hemodialysis. The use of calcium-free phosphate-binding agents that are not associated with the risk for developing hypercalcemia can slow the development of vascular calcification, reduce the incidence of adverse cardiovascular events and mortality in patients with chronic kidney disease.


2021 ◽  
Author(s):  
Weichen Zhang ◽  
Guoxin Ye ◽  
Zhaori Bi ◽  
Weisheng Chen ◽  
Jing Qian ◽  
...  

Abstract Background: Estimation of phosphate load in hemodialysis patients is always controversial in clinical practice. The aim of this study was to verify individual achievement rate of serum phosphate as the evaluation of phosphate load through investigating its impact on cardiovascular mortality in hemodialysis patients.Methods: This was a single-center, retrospective cohort study. A total of 251 maintenance hemodialysis patients were enrolled. The individual achievement rate of serum phosphate was defined as the times of tests within the target range divided by total times of tests over a period of time. Cox regression model was used to examine the relationship between individual achievement rate of serum phosphate and cardiovascular mortality. Results: The mean age of the study population was 61±13 years old. A total of 44 (17.5%) patients died from cardiovascular disease (CVD) during a median follow-up of 65 months. Multivariable Cox analysis showed that one-year serum phosphate achievement rate of 0% (HR=4.117, P=0.016) and 25% (HR=3.343, P=0.023) increased the risk of cardiovascular mortality while the achievement rate of 50% (HR=2.129, P=0.162) and 75% (HR=1.080, P=0.902) did not, compared to the rate of 100%. Urea reduction ratio (URR) was positively, while serum intact parathyroid hormone (iPTH), alkaline phosphatase (ALP), normalized protein catabolic rate (nPCR), and total phosphate-binding capacity of drug were negatively associated with achievement in target of serum phosphate.Conclusions: Keeping one-year achievement rate of serum phosphate higher than 50% provides significant clinical benefits in reducing cardiovascular mortality.


2022 ◽  
Vol 12 (1) ◽  
Author(s):  
Hiroaki Tsujikawa ◽  
Shunsuke Yamada ◽  
Hiroto Hiyamuta ◽  
Masatomo Taniguchi ◽  
Kazuhiko Tsuruya ◽  
...  

AbstractWomen have a longer life expectancy than men in the general population. However, it has remained unclear whether this advantage is maintained in patients undergoing maintenance hemodialysis. The aim of this study was to compare the risk of mortality, especially infection-related mortality, between male and female hemodialysis patients. A total of 3065 Japanese hemodialysis patients aged ≥ 18 years old were followed up for 10 years. The primary outcomes were all-cause and infection-related mortality. The associations between sex and these outcomes were examined using Cox proportional hazards models. During the median follow-up of 8.8 years, 1498 patients died of any cause, 387 of whom died of infection. Compared with men, the multivariable-adjusted hazard ratios (95% confidence interval) for all-cause and infection-related mortality in women were 0.51 (0.45–0.58, P < 0.05) and 0.36 (0.27–0.47, P < 0.05), respectively. These findings remained significant even when propensity score-matching or inverse probability of treatment weighting adjustment methods were employed. Furthermore, even when the non-infection-related mortality was considered a competing risk, the infection-related mortality rate in women was still significantly lower than that in men. Regarding all-cause and infection-related deaths, women have a survival advantage compared with men among Japanese patients undergoing maintenance hemodialysis.


2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Jong Hyun Jhee ◽  
Seun Deuk Hwang ◽  
Joon Ho Song ◽  
Seoung Woo Lee

AbstractThe optimal vascular access type for elderly hemodialysis patients is controversial. We evaluated the impact of comorbidity burden on the association between vascular access type and mortality risk among 23,100 hemodialysis patients aged ≥65 years from the Korean Society of Nephrology End-Stage Renal Disease registry data. Subjects were stratified into tertiles according to the simplified Charlson comorbidity index (sCCI), and the survival and hospitalization rates were compared with respect to vascular access type: arteriovenous fistula (AVF), arteriovenous graft (AVG), and central venous catheter (CVC). Among all tertiles of sCCI, CVC use showed highest risk of mortality than AVF use. In the lowest to middle tertile, no difference was observed in survival rates between the use of AVF and AVG. However, in the highest tertile, AVG use showed higher risk of mortality than AVF use. When subjects were classified according to a combination of sCCI tertile and access type (AVF vs. AVG), patients with the highest CCI with AVG showed 1.75-folded increased risk of mortality than those with the lowest sCCI with AVF. Hospitalization rates due to access malfunction were highest in patients with CVC in all sCCI tertiles. In the highest tertile, patients with AVG showed increased rates of hospitalization compared to those with AVF due to access malfunction. However, hospitalization rates due to access infection were highest in patients with AVG in all tertiles. The use of AVF may be of benefit and switching to AVF should be considered in elderly hemodialysis patients with a high burden of comorbidity.


Sign in / Sign up

Export Citation Format

Share Document